首页 产品目录 分子砌块 按反应类型 五元杂环胺化 (13S)-26-(3-(2-(二螺[2.0.24.13]庚烷-7-基)乙氧基)-1H-吡唑-1-基)-15,15-二甲基-61,62-二氢-5-硫杂-4,7-二氮杂-2(2,3),6(6,2)-二吡啶并-1(1,3)-吡咯烷环癸番-3-酮 5,5-二氧化物

(13S)-26-(3-(2-(二螺[2.0.24.13]庚烷-7-基)乙氧基)-1H-吡唑-1-基)-15,15-二甲基-61,62-二氢-5-硫杂-4,7-二氮杂-2(2,3),6(6,2)-二吡啶并-1(1,3)-吡咯烷环癸番-3-酮 5,5-二氧化物

(13S)-26-(3-(2-(dispiro[2.0.24.13]heptan-7-yl)ethoxy)-1H-pyrazol-1-yl)-15,15-dimethyl-61,62-dihydro-5-thia-4,7-diaza-2(2,3),6(6,2)-dipyridina-1(1,3)-pyrrolidinacyclodecaphan-3-one 5,5-dioxide

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量
1mg 98% 询价
- +
5mg 98% 询价
- +
10mg 98% 询价
- +
25mg 98% 询价
- +
50mg 98% 询价
- +
100mg 98% 询价
- +
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

2374124-49-7

中文名称

(13S)-26-(3-(2-(二螺[2.0.24.13]庚烷-7-基)乙氧基)-1H-吡唑-1-基)-15,15-二甲基-61,62-二氢-5-硫杂-4,7-二氮杂-2(2,3),6(6,2)-二吡啶并-1(1,3)-吡咯烷环癸番-3-酮 5,5-二氧化物

英文名称

(13S)-26-(3-(2-(dispiro[2.0.24.13]heptan-7-yl)ethoxy)-1H-pyrazol-1-yl)-15,15-dimethyl-61,62-dihydro-5-thia-4,7-diaza-2(2,3),6(6,2)-dipyridina-1(1,3)-pyrrolidinacyclodecaphan-3-one 5,5-dioxide

别名

13H-17,20-Methano-8,12-nitrilo-12H-pyrido[3,2-d][1,2,6,13]thiatriazacyclooctadecin-5(6H)-one, 2-[3-(2-dispiro[2.0.2.1]hept-7-ylethoxy)-1H-pyrazol-1-yl]-14,15,16,17,18,19-hexahydro-19,19-dimethyl-, 7,7-dioxide, (17S)-;Vanzacaftor;Vanzacafter;Vanzacaftor (Synonyms: VX-121)

标准英文名

(13S)-26-(3-(2-(dispiro[2.0.24.13]heptan-7-yl)ethoxy)-1H-pyrazol-1-yl)-15,15-dimethyl-61,62-dihydro-5-thia-4,7-diaza-2(2,3),6(6,2)-dipyridina-1(1,3)-pyrrolidinacyclodecaphan-3-one 5,5-dioxide

分子式

C32H39N7O4S

分子量

617.28

精确分子量

617.28

SMILES

CC(C)(C[C@@](CCC/N=C1NC(S(=O)(N2)=O)=CC=C\1)([H])C3)N3C4=NC(N(C=C5)N=C5OCCC6C7(CC7)C68CC8)=CC=C4C2=O

标准SMILES

CC1(C)C[C@@H]2CCCN=C3C=CC=C(N3)S(=O)(=O)NC(=O)C3=CC=C(N=C3N1C2)N1C=CC(=N1)OCCC1C2(CC2)C21CC2

用途

Vanzacaftor is an orally active, novel cystic fibrosis transmembrane conductance regulator (CFTR) modulator. In combination with Tezacaftor and Deutivacaftor, it improves the processing and trafficking of the CFTR protein and enhances chloride transport. The Vanzacaftor-Tezacaftor-Deutivacaftor combination is safe and well-tolerated, and it improves lung function, respiratory symptoms, and CFTR function in patients with cystic fibrosis, showing promise for research and therapeutic applications in cystic fibrosis.

InChIKey

VCSUIBJKYCVWNF-NRFANRHFSA-N

安全信息

SureRoute逆合成路线

1.  2374124-49-7 逆合成路线 1

—
—
ACYRBW908
2374124-49-7
来源: SureRoute

2.  2374124-49-7 逆合成路线 2

—
—
—
—
ACYRBW908
2374124-49-7
来源: SureRoute

3.  2374124-49-7 逆合成路线 3

—
—
ACYRBW908
2374124-49-7
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手